Latest Breaking News On - Head investor relations - Page 5 : comparemela.com

Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy in Neurology

Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy in Neurology
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Pratteln
Switzerland-general
Switzerland
United-states
Germany
United-kingdom
America
Swiss
German
Eva-kalias
Drug-administration
Santhera-pharmaceuticals

Biotalys NV: Information on the total number of voting rights and shares

Biotalys NV: Information on the total number of voting rights and shares
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Belgium
Belgian
Biotalys-persbericht-noemer
Stefan-klotter
Toon-musschoot
Belgian-financial-services
Agricultural-technology-agtech
Agricultural-technology
Company-or-biotalys
Biotalys-press-release-denominator
Belgian-act
Markets-authority

Santhera Launches AGAMREE® (Vamorolone) in Germany as First Market for the Treatment of Duchenne Muscular Dystrophy

Santhera Launches AGAMREE® (Vamorolone) in Germany as First Market for the Treatment of Duchenne Muscular Dystrophy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Liechtenstein
United-kingdom
Pratteln
Switzerland-general
Switzerland
Iceland
United-states
Norway
Germany
German
Swiss
America